Jansen, Iris E. http://orcid.org/0000-0003-1901-8131
Savage, Jeanne E. http://orcid.org/0000-0002-2034-8341
Watanabe, Kyoko
Bryois, Julien
Williams, Dylan M.
Steinberg, Stacy http://orcid.org/0000-0001-7726-5152
Sealock, Julia
Karlsson, Ida K.
Hägg, Sara http://orcid.org/0000-0002-2452-1500
Athanasiu, Lavinia
Voyle, Nicola
Proitsi, Petroula http://orcid.org/0000-0002-2553-6974
Witoelar, Aree
Stringer, Sven http://orcid.org/0000-0003-3115-8532
Aarsland, Dag
Almdahl, Ina S. http://orcid.org/0000-0001-6070-4921
Andersen, Fred
Bergh, Sverre
Bettella, Francesco
Bjornsson, Sigurbjorn
Brækhus, Anne
Bråthen, Geir http://orcid.org/0000-0003-3224-7983
de Leeuw, Christiaan http://orcid.org/0000-0003-1076-9828
Desikan, Rahul S.
Djurovic, Srdjan http://orcid.org/0000-0002-8140-8061
Dumitrescu, Logan
Fladby, Tormod
Hohman, Timothy J. http://orcid.org/0000-0002-3377-7014
Jonsson, Palmi V.
Kiddle, Steven J. http://orcid.org/0000-0003-4350-7437
Rongve, Arvid
Saltvedt, Ingvild
Sando, Sigrid B.
Selbæk, Geir
Shoai, Maryam
Skene, Nathan G. http://orcid.org/0000-0002-6807-3180
Snaedal, Jon
Stordal, Eystein http://orcid.org/0000-0002-2443-7923
Ulstein, Ingun D.
Wang, Yunpeng
White, Linda R.
Hardy, John
Hjerling-Leffler, Jens http://orcid.org/0000-0002-4539-1776
Sullivan, Patrick F.
van der Flier, Wiesje M.
Dobson, Richard http://orcid.org/0000-0003-4224-9245
Davis, Lea K. http://orcid.org/0000-0001-5143-2282
Stefansson, Hreinn
Stefansson, Kari http://orcid.org/0000-0003-1676-864X
Pedersen, Nancy L.
Ripke, Stephan
Andreassen, Ole A. http://orcid.org/0000-0002-4461-3568
Posthuma, Danielle http://orcid.org/0000-0001-7582-2365
Article History
Received: 1 March 2018
Accepted: 9 November 2018
First Online: 7 January 2019
Change Date: 6 February 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: The authors report the following potentially competing financial interests. P.F.S.: Lundbeck (advisory committee), Pfizer (Scientific Advisory Board member), and Roche (grant recipient, speaker reimbursement). J.H.L.: Cartana (Scientific Advisor) and Roche (grant recipient). O.A.A.: Lundbeck (speaker’s honorarium). St.St., H.S., and K.S. are employees of deCODE Genetics/Amgen. J.H. is a cograntee of Cytox from Innovate UK (UK Department of Business). D.A. has received research support and/or honoraria from Astra-Zeneca, Lundbeck, Novartis Pharmaceuticals, and GE Health, and serves as a paid consultant for Lundbeck, Eisai, Heptares, and Axovant. All other authors declare no financial interests or potential conflicts of interest.